Dihydralazine hydrochloride

This classification denotes an antihypertensive agent with the molecular formula C8H10N6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OVG1TP7A10, chemically known as 2,3-dihydrophthalazine-1,4-dione dihydrazone monohydrochloride but more generally known as dihydralazine hydrochloride, which bears US NIH Compound Identifier 198456. European Medicines Agency schedules Dihydralazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01701MIG. Most nations, for tariff and trade purposes, schedule dihydralazine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, DIHYDRALAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dihydralazine hydrochloride bears US NLM identifiers UMLS ID C3273349 and NCI Concept Code C97308. SMILES: C1CCC2C(C1)C(NNC2NN)NN.CL.